Emily K Wiggins (Emily Wiggins)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Prostate Cancer

Radical Prostatectomy

Top Venues

ClinicoEconomics and outcomes research : CEOR

This page only lists publications with an associated author ORCID identifier.

Publications

Dusica Hadzi Boskovic, Shuting Liang, Purva Parab, Emily K Wiggins, Joshua N Liberman
Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Dusica Hadzi Boskovic, Shuting Liang, Purva Parab, Emily K Wiggins, Joshua N Liberman
Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Dusica Hadzi Boskovic, Shuting Liang, Purva Parab, Emily K Wiggins, Joshua N Liberman
Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Adela Ramirez-Torres, Allison L Reagan, Lauren E Howard, Emily K Wiggins, Adriana C Vidal, Junxiang Wan, Brendan Miller, Stephen J Freedland, Pinchas Cohen
Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities. The Prostate 82 (13) (2022)
Emily K Wiggins, Taofik Oyekunle, Lauren E Howard, Sarah C Markt, Lorelei A Mucci, Donald L Bliwise, Daniel M Moreira, Gerald L Andriole, Martin L Hopp, Stephen J Freedland, Emma H Allott
Sleep quality and prostate cancer aggressiveness: Results from the REDUCE trial. The Prostate 80 (15) (2020)